A better delivery system for chemotherapy drugs

Professor Daniel Wreschner of Tel Aviv University is developing new antibodies that bind to and kill off cancer cells exclusively. These antibodies have the potential to be used as a more efficient and effective method of delivering chemotherapy drugs directly to their targets. Read more